Paying user area
Try for free
Shockwave Medical Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Net Profit Margin since 2019
- Total Asset Turnover since 2019
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Shockwave Medical Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26, 2024 | = | ÷ | = | ÷ | |||||||
Feb 27, 2023 | = | ÷ | = | ÷ | |||||||
Feb 25, 2022 | = | ÷ | = | ÷ | |||||||
Feb 26, 2021 | = | ÷ | = | ÷ | |||||||
Mar 12, 2020 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Shockwave Medical Inc. Annual Report.
The analysis of the financial data reveals several notable trends over the five-year period ending February 26, 2024.
- Share Price
- The share price exhibited substantial growth over the analyzed period. Starting from a value of $29 in March 2020, it increased significantly to $259.89 by February 2024. This represents a nearly ninefold increase, highlighting strong market performance and investor confidence during this timeframe.
- Earnings Per Share (EPS)
- The EPS shows a marked improvement over the period. Initially, the company reported negative earnings per share, with a loss of $1.61 in March 2020, which further deteriorated slightly to -$1.89 in February 2021. However, from 2022 onwards, there is a positive turnaround; EPS rose to -$0.26 in February 2022, then sharply improved to $5.92 in February 2023, before slightly decreasing to $3.94 in February 2024. This positive trend signifies increasing profitability after a phase of losses, suggesting effective operational management and possible revenue growth.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio data is only available for the last two years. It was 32.02 in February 2023 and substantially increased to 65.99 in February 2024. The rising P/E ratio suggests that the market's valuation of the company has grown relative to its earnings, possibly reflecting heightened investor expectations or speculative premium given the improved profitability.
Overall, the data indicates a company transitioning from a loss-making position towards profitability, accompanied by a remarkable increase in share price and elevated market valuation levels. The period from 2022 to 2024 is particularly notable for the sharp improvement in both earnings and stock market performance.
Comparison to Competitors
Shockwave Medical Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|
Feb 26, 2024 | ||||||
Feb 27, 2023 | ||||||
Feb 25, 2022 | ||||||
Feb 26, 2021 | ||||||
Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Comparison to Sector (Health Care Equipment & Services)
Shockwave Medical Inc., P/E, long-term trends, comparison to sector (health care equipment & services)
Shockwave Medical Inc. | Health Care Equipment & Services | |
---|---|---|
Feb 26, 2024 | ||
Feb 27, 2023 | ||
Feb 25, 2022 | ||
Feb 26, 2021 | ||
Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Comparison to Industry (Health Care)
Shockwave Medical Inc. | Health Care | |
---|---|---|
Feb 26, 2024 | ||
Feb 27, 2023 | ||
Feb 25, 2022 | ||
Feb 26, 2021 | ||
Mar 12, 2020 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).